NCT02572245View on ClinicalTrials.gov

A Study of PF-06410293 Following Subcutaneous Administration Using A Prefilled Syringe Or A Prefilled Pen In Healthy Adult Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

164

Participants

Timeline

Start Date

January 31, 2016

Primary Completion Date

May 31, 2016

Study Completion Date

May 31, 2016

Conditions
Healthy Subjects
Interventions
DEVICE

PF-06410293 PFS

PF-06410293 40 mg administered subcutaneously by Prefilled syringe

DEVICE

PF-06410293 PFP

PF-06410293 40 mg administered subcutaneously by prefilled pen

Trial Locations (1)

78209

ICON Early Phase Services, LLC, San Antonio

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT02572245 - A Study of PF-06410293 Following Subcutaneous Administration Using A Prefilled Syringe Or A Prefilled Pen In Healthy Adult Subjects | Biotech Hunter | Biotech Hunter